UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063638
Receipt number R000072832
Scientific Title Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Autonomic Recovery Following Cognitive Stress: A Randomized Sham-Controlled Pilot Trial
Date of disclosure of the study information 2026/11/16
Last modified on 2026/11/16 09:35:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of transcutaneous auricular vagus nerve stimulation on heart rate variability following cognitive stress

Acronym

Autonomic Recovery after Cognitive Stress with taVNS

Scientific Title

Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Autonomic Recovery Following Cognitive Stress: A Randomized Sham-Controlled Pilot Trial

Scientific Title:Acronym

Autonomic Recovery after Cognitive Stress with Transcutaneous auricular vagus nerve stimulation

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to clarify the effects of transcutaneous auricular vagus nerve stimulation on heart rate variability following the Stroop task in healthy adult men.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

High-frequency components in heart rate variability analysis: Measured during rest (5 minutes), the Stroop task (20 minutes), the stimulus phase (10 minutes), and recovery (10 minutes).

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Participants are randomly assigned to either the taVNS group or the sham group. For the taVNS stimulation, the stimulation site is the left tragus, and stimulation is applied at 25 Hz for 10 minutes. For the sham stimulation, the stimulation site is the left earlobe. The stimulation intensity is set between the pain threshold and the sensory threshold.

Interventions/Control_2

Participants are randomly assigned to either the taVNS group or the sham group. For the taVNS stimulation, the stimulation site is the left tragus, and stimulation is applied at 25 Hz for 10 minutes. For the sham stimulation, the stimulation site is the left earlobe. The stimulation intensity is set between the pain threshold and the sensory threshold.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

25 years-old >=

Gender

Male

Key inclusion criteria

Ages 18-25
Individuals from whom written consent to participate in the study of their own free will can be obtained

Key exclusion criteria

Individuals with current conditions such as sprains or fractures
Individuals with a history of cardiovascular disease
Individuals with a history of neurological disorders
Individuals with a history of psychiatric or metabolic disorders
Individuals currently taking medications that affect autonomic nervous system function
Individuals with ear conditions, skin conditions, injuries, or other conditions that would prevent the placement of a taVNS electrode
Individuals who are unable to understand the informed consent form for this study

Target sample size

25


Research contact person

Name of lead principal investigator

1st name Daisuke
Middle name
Last name Fujita

Organization

Fukuoka International University of Health and Welfare

Division name

Department of Physical Therapy

Zip code

8140001

Address

3-6-40 Momochihama, Sawara Ward, Fukuoka City, Fukuoka Prefecture

TEL

0928321200

Email

d-fujita.tg@ihwg.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Fujita

Organization

Fukuoka International University of Health and Welfare

Division name

Department of Physical Therapy

Zip code

8140001

Address

3-6-40 Momochihama, Sawara Ward, Fukuoka City, Fukuoka Prefecture

TEL

0928321200

Homepage URL


Email

d-fujita.tg@ihwg.jp


Sponsor or person

Institute

Fukuoka International University of Health and Welfare

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Review Committee, Fukuoka International University of Health and Welfare

Address

3-6-40 Momochihama, Sawara Ward, Fukuoka City, Fukuoka Prefecture

Tel

0928321200

Email

fiuhw-rinri@ihwg.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

16

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 01 Month 25 Day

Date of IRB

2023 Year 01 Month 25 Day

Anticipated trial start date

2023 Year 02 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The study was conducted before clinical trial registration, and retrospectively registered.


Management information

Registered date

2026 Year 11 Month 16 Day

Last modified on

2026 Year 11 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072832